ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000536.1|Nisin_1 # 173 # 346 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.374	BGC0000536.1|Nisin_1 	173	346	+	Loose	1200	21.9422	LRA-13	36.36	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	ATGAGTACAAAAGATTTCAACTTAGATTTGGTATCTGTTTCAAAAACAGATTCTGGCGCTTCAACACGTATTACCAGCATTTCGCTTTGTACACCAGGTTGTAAAACAGGTGTTCTGATGGGATGTAACCTGAAAACAGCAACTTGTAATTGTAGCGTTCACGTAAGCAAATAA	MSTKDFNLDLVSVSKTDSGASTRITSISLCTPGCKTGVLMGCNLKTATCNCSVHVSK	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	9.36	gnl|BL_ORD_ID|1764|hsp_num:0	1912			1668	1761	
BGC0000536.1|Nisin_2 # 453 # 3434 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.324	BGC0000536.1|Nisin_2 	453	3434	+	Loose	710	32.3426	tet(35)	26.73	3000481	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATTCAAAACTCATTTAAAGCACAGCCCTTTTTAGTAAGAAATACAATTTTATCCGTTAAAGATAAGCAGAGTTTTACTGAATACACCCAAGTCATTGAGACTGCGAATAATAATAAAGTCTTTTTGGAGCAGTTACTTATAGCCAATCCAAAACTCTATGATACCTTGCAGAAATATAATGCTGGTCTGTTAAAGAAAAAAAGAGTAAAAAAATTATTTGAGTCTGTTTATAAGTATTATAAGAGAAGCTATTTACGTTCTACTCCATTCGGGTTGTTTAGTGAAACTTCGATTGGTACCTTTTCAGAAAATTCAAAGTCAGAGTTAAATGGAGAAACTACAAAGGGGGTGATATTGGACACTCAGTGGTTAATTCGTTTGGTTCATCAAATGGAACGTGACTTCTCAAGAAAGCTATCATTTGTTATTAATAACGCGAATTATGAATTTGGGGACCGAATTTTTCAAGTTTATACTATTAACAGTAGTGATCTTGAAGAGGTAAATATTAAATCCACAAATGTTTATCAAATAATATCCAAGACTTGTGAAAGTGGTTTTCAAAAATATGAAGAAATCTGTGAAAGTGTAACGGCGAGCTACGGAGATGAATATAGGGAGCTTTCAGAACAATATATTAATAGTCTGATAGTCAATCATTATTTGGTTTCTAATCTGCAAAAAGATATATTATCAGATTTTTCCTGGGAAACTTTTCTGAATAAAGTTGAGGAGATAGATGATAGCAAAAAGTACCTTATTCCTTTAAAAAGAGTCCAAAAGCTAATTCAAGAGTACTCTGAATTAGAAATTGGCGAAGGTCTTGAGAAGCTGAAAGAAATATATCAAGAAATGTCACAAATTCTTGCGAACGATAATTATATTCAAATTGATTTATTTAGTGATAGTGAAATAACTTTTGATACTGAGCAAAAGCAGCAGTTGGAGCGTTTAGCTGACTTCATAGGAAATACGACAAAATCTGTAAACAGAACATACTTGGATGACTATAAAGATAAGTTTATTGAAAAGTATGGAGTAGATCAGGAGGTACAGATAGTAGAATTATTTGATTCAACATTTGGTATAGGAGCCCCATATAATTACACTCATCCTCAAAATGATTTTTATGAGTTAGAACCAAACACAGCTTACTTCTCAGAAGAGGAAAGAGAAAAGTACCTCAGTAAGTATGTGGAAGCCATTAAAAATAATGAGGCAATTAATTTTGAAGATTTAGAATCTCATTACCAAAAAATAGCAGCGGAAAAGAATAGCAAACTTCAAGGGCTAGAATTATTTTTAGATCTTGCAAAGAAGGACGAAAAGGATATTTTTGTCTTAGGAAACATTATTGGAAATAACAACCTTGGAGGGGCATCTGGTAGGTTCTCAGCACTATCCCCAGAGTTAAAAAATTATCATAAATCCATAGTAGATTCTATTGAGAAAGAAAACGAGAGTAAAGGAATTACATCCTGTGAAATTGTGTTCTTACCTGAAAATATTAGGCATGCTAATGTTATGCATACGTCAATTGAGAGAAAAAGGGTACTTCCAGTTTTTACAAGTACGAGCCATGATGAGGTTCAGTTAACCAACATCTATATTGGAATAGATGACAATGAAGAATTTTACGCACGAGATATTTCAACTCAAGAGGTACTAAAGTTTTACGTTACTAGTATGTATAATAAAACATTATTTAGCAACGAACTTAGATTCCTCTACGAAATTTCATTGGATGATAATTTTGGTAACTTGCCTTGGGAACTTATTTACAGAGATTTTGACTATGTTCCCCGTTTAGTATTTGGAGACATAGTTGTTTCTCCTGCTAAGTGGAAAATTCGGGAGGAAGATATGAAAACTGAAGAAATAACAAAGGAATTTCTTCAAAGTAAAGGAGTTCCTAAGGAGTTTTATATCGTCAATGGAGATAATAAAGTTTATTTATCACAAGAAAATCTGTTGGATATGAGTATGTTAGAGGCACAAATAAAGAAGAGTGCTAAAAGAAATGATTTTGTAGAGCTCCAAGAATATATTGAAGATGGTGATGTGGTAAGTAAAAGGCAAAAAGGTAGGGTTTCGGATGTAGTTGTTCCTTTTGTTAGAAAGACAACACCAGATAATGATAGTAAGAAATTTACAAGAGAAAAAAGGGTTTCAGTTGAACAGCGTGAGAAATTGCCCTTCACGGATTGGCTTTACATTAAGTTGTATATTTCTACAAACCGTCAAGATGAATTTTTACTATCCTATCTTCCAGAAATTCAGGAAATAATAGAAAATCTGGGAGGACAACTATTCTTTCTAAGATATACTGACCCTCAGCCTCACATACGATTGCGTATAAAATGCTCAAACTTGTTTTTAGCCTATAATTCCATTCTTGAAATTTTAAAAAAGAGTAGAGAAAATAGGGTAATGTCAACTTTTGATATTTCTACCTATGACCAAGAGGTAGAAAGATATGGTGGCTTTGAAACATTAGAATTATCCGAGCAAATATTTTGTGCTGATTCTAAAACTATTCCAACTCTACTTACGGTTACAAAAGAGGCTAATAATGATTGGAGTGTTGATGATGTATCAATCTTGATGGATTATAGGTATCTGAAATGGTTTTTCCAGAACGATAATCAAGAAATCCTTAAATTTTTGCATTTAGTTAGTCCTGAAAAAGTTGAGGAAAATGTCAATGAAAAGATTGTACATTATCATAATCTTCTGGAAACCGATAATCTGGATGGGCGCATTTTTAGTGATAAGAACTTTGAAGATTTGAAGCGTACTGTAGAAGCTCTATTTTACAAAATGGTATCTCAAAATTATGATACTCAGAAGGTTTATTCAATTATTGATAGCATCATTCACGTTCATAACAACAGATTAATTGGCATTAACCGAGATAAAGAGAAAGTGATTTATTATGGCCTTCAAAGGTTATTTACTTCGGAAGAATACATGAAATGA	MIQNSFKAQPFLVRNTILSVKDKQSFTEYTQVIETANNNKVFLEQLLIANPKLYDTLQKYNAGLLKKKRVKKLFESVYKYYKRSYLRSTPFGLFSETSIGTFSENSKSELNGETTKGVILDTQWLIRLVHQMERDFSRKLSFVINNANYEFGDRIFQVYTINSSDLEEVNIKSTNVYQIISKTCESGFQKYEEICESVTASYGDEYRELSEQYINSLIVNHYLVSNLQKDILSDFSWETFLNKVEEIDDSKKYLIPLKRVQKLIQEYSELEIGEGLEKLKEIYQEMSQILANDNYIQIDLFSDSEITFDTEQKQQLERLADFIGNTTKSVNRTYLDDYKDKFIEKYGVDQEVQIVELFDSTFGIGAPYNYTHPQNDFYELEPNTAYFSEEEREKYLSKYVEAIKNNEAINFEDLESHYQKIAAEKNSKLQGLELFLDLAKKDEKDIFVLGNIIGNNNLGGASGRFSALSPELKNYHKSIVDSIEKENESKGITSCEIVFLPENIRHANVMHTSIERKRVLPVFTSTSHDEVQLTNIYIGIDDNEEFYARDISTQEVLKFYVTSMYNKTLFSNELRFLYEISLDDNFGNLPWELIYRDFDYVPRLVFGDIVVSPAKWKIREEDMKTEEITKEFLQSKGVPKEFYIVNGDNKVYLSQENLLDMSMLEAQIKKSAKRNDFVELQEYIEDGDVVSKRQKGRVSDVVVPFVRKTTPDNDSKKFTREKRVSVEQREKLPFTDWLYIKLYISTNRQDEFLLSYLPEIQEIIENLGGQLFFLRYTDPQPHIRLRIKCSNLFLAYNSILEILKKSRENRVMSTFDISTYDQEVERYGGFETLELSEQIFCADSKTIPTLLTVTKEANNDWSVDDVSILMDYRYLKWFFQNDNQEILKFLHLVSPEKVEENVNEKIVHYHNLLETDNLDGRIFSDKNFEDLKRTVEALFYKMVSQNYDTQKVYSIIDSIIHVHNNRLIGINRDKEKVIYYGLQRLFTSEEYMK	MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFGLDIGKMREHEIAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGGQALAADGKEFVLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVFAWTIGSVIGDMKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVALMLPMLSAVLAGAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFSFIAASITFVIVCAILSWLSKSKMASCQNA	269.11	gnl|BL_ORD_ID|1927|hsp_num:0	1969			117	417	tetracycline
BGC0000536.1|Nisin_3 # 3445 # 5247 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.331	BGC0000536.1|Nisin_3 	3445	5247	+	Loose	1190	133.65	novA	22.91	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGATGAAGTGAAAGAGTTCACATCAAAACAATTTTTTAATACGTTGCTTACCCTTCCGAGTACCTTGAAATTAATTTTTCAGTTAGAAAAACGGTATGCTCTCTATCTAATTGTTCTAAATGCTATTGCTGCTTTTGTTCCATTAGCAAGTCTCTTTATCTACCAAGATTTGATAAATTCTGTGTTAGGGTCAGGAAGGCATCTTATCAATATTATTGTCATCTATTTCATTGTCCAAGTGATAACCACAGTTTTGGGACAATTAGAAAATTATTTCAGTGGGAAATTTGATATGCGGCTTTCTTACAGCATTAATATGCGACTTATGAAAACTACCTCATCTCTTGAATTAAGCGATTATGAACAGGCGGATATGTATAATATCATTGAAAAGGTTACACAAGATAGCACTTATAAACCTTTTCAGCTATTCAATGCTATCATTGTAGTGCTTTCATCGTTTATTTCATTATTATCTAGTTTGTTTTTTATTGGGACATGGAACATTGGAGTAGCATTTTTACTCCTTATTGTTCCAATATTATCTTTGATCCTCTTCCTTAGAGTGGGACAACTAGAGTTTTTGATCCAGTGGCAAAGAGCTAACTCTGAAAGAGAGACATGGTACATTGTCTATTTATTGACTCATGATTTTTCTTTTAAAGAAATCAAGTTGAATAATATTAGCAACTATTTTATTGGCAAATTCGGGAAGCTAAAAAAAGGTTTTATCAACCAAGATTTAGCGATTGCCCGTAAAAAGACATACTTCAATATTTTGCTGGATTTTATATTGAACTTGATAAATATTCTTACAATATTTGCCATGATCCTATCAGTTAGAGCAGGAAAACTTCTCATTGGTAATTTGGTAAGCCTCATACAGGCTATTTCCAAAATTAATACCTATTCTCAGTCAATGATTCAAAATATTTACATCATCTATAATACCAGTTTGTTTATGGAACAACTTTTTGACTTTCTAAAAAGAGAAAATGTGGTTCAAAAGAATGTAGAGAGGATTGAAACGCACTATCATGATATAGAAACTGTTAAAGTGTCCAATTTGTCCTATGCTTATCCCAATTCAAATAATTTTGCGTTAAAAAATGTTGATTTATCTTTTGAAAAAGGAGAGTTAACAGCTATAGTAGGGAAAAATGGTTCAGGGAAAAGTACATTAGTGAAAATAATTTCAGGATTATACCAACCGACAAAGGGCAAAGTCCAATATGATAACAGGGGAAATAATTTGTTGTCTGAGGAGTTTTATCAGAGAAATATATCAGTACTATTCCAAGATTTTGTGAAGTATGAGTTAACGGTGAGAGAGAATATCGGATTGAGTGACTTGTCTTCTCCATGGAAAGATGAGGATATTATCAAAGTGCTAGATAATTTAGGGCTTGACTTCCTGAAAGTCAATGATCGGTACGCCCTTGATACGCAACTAGGAAATTGGTTTCAAGAAGGTCGTCAACTTTCAGGAGGGCAGTGGCAAAAAATTGCGCTTGCAAGGACATTCTTTAAGAAAGCTGCAATTTATATTTTGGATGAACCAAGTGCTGCCCTTGATCCCGTGGCTGAAAAAGAAATATTTGACTACTTTGTCAAGCTATCAGAAAATAATATTTCAATTTTTATTTCTCATAGTTTGAATGCTGCTCGAAAAGCAAATAAAATCGTGGTTATGAAAGATGGACAAGTTGAAGATGTTGGAAATCACGATGACCTTCTGAAAAGATGTCAGTATTATCAAGAACTTTACTATTCAGAGCAATATGAGGATAATGATGAATAA	MDEVKEFTSKQFFNTLLTLPSTLKLIFQLEKRYALYLIVLNAIAAFVPLASLFIYQDLINSVLGSGRHLINIIVIYFIVQVITTVLGQLENYFSGKFDMRLSYSINMRLMKTTSSLELSDYEQADMYNIIEKVTQDSTYKPFQLFNAIIVVLSSFISLLSSLFFIGTWNIGVAFLLLIVPILSLILFLRVGQLEFLIQWQRANSERETWYIVYLLTHDFSFKEIKLNNISNYFIGKFGKLKKGFINQDLAIARKKTYFNILLDFILNLINILTIFAMILSVRAGKLLIGNLVSLIQAISKINTYSQSMIQNIYIIYNTSLFMEQLFDFLKRENVVQKNVERIETHYHDIETVKVSNLSYAYPNSNNFALKNVDLSFEKGELTAIVGKNGSGKSTLVKIISGLYQPTKGKVQYDNRGNNLLSEEFYQRNISVLFQDFVKYELTVRENIGLSDLSSPWKDEDIIKVLDNLGLDFLKVNDRYALDTQLGNWFQEGRQLSGGQWQKIALARTFFKKAAIYILDEPSAALDPVAEKEIFDYFVKLSENNISIFISHSLNAARKANKIVVMKDGQVEDVGNHDDLLKRCQYYQELYYSEQYEDNDE	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	97.56	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1779	novobiocin
BGC0000536.1|Nisin_5 # 6478 # 7215 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.375	BGC0000536.1|Nisin_5 	6478	7215	+	Loose	880	24.6386	arlS	35.14	3000839	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAAAAATATTTATTGTTAATTGTAGCTCTGCTAGGAATGACAAGCTTAGCAGGGTGCTACCAAACAAGTCAAAAAGAAGTGCGCTTCGAAAAAGGAAGCTATAAAAATTTTGTTTATGATAATAAGTCATACTTTGTGACCGATAAGCAAATTTCTCAAGGCAGCGTAAACAATTCCAAAGCAAAATTTTACAAGCTGTTGATTGTTGACGCGAAAAGCGAGAAAGTTTTATCCAGCAGCAACAAAAATAGTGTGACTTTAGCTTTTAACAATATTTATCAAACTTCTGACAAGTCGCTCTGCATGGGTGTTAATGATAAATACTATCAAGTGCTGCCAGAAAGTAATGAGGGAACGGTTAAAGCTTTAAGCCTGCAAAATTTTGACCAGACAGGCGATAATTCCGATGACAATTTCTCCATTGATAAAAACGACGCACGAAAAATTGACTATAAAGGCAATATTTACAGTGTATCAGACAAATCCGTGCCTGACGACGAATTGGGAGAATTTCAAGATGTTCTAGCTGAAGTCCGTGTCTTTGATTCGACAACAGGTAAAACTATTCCCAAGTCTGACTGGGGAAAAATTGACAACGGCGAATCGATTTCCAAACAGAATCGGACAGAATGGGACTACGGCGAAATTCATTCGATTAAGGGAAAAGCTATGACTGAAACATTTGCCATTGAGATAAATGATGACTTTAAGCTCGCAACGAAGGCAGGAAATTAG	MKKYLLLIVALLGMTSLAGCYQTSQKEVRFEKGSYKNFVYDNKSYFVTDKQISQGSVNNSKAKFYKLLIVDAKSEKVLSSSNKNSVTLAFNNIYQTSDKSLCMGVNDKYYQVLPESNEGTVKALSLQNFDQTGDNSDDNFSIDKNDARKIDYKGNIYSVSDKSVPDDELGEFQDVLAEVRVFDSTTGKTIPKSDWGKIDNGESISKQNRTEWDYGEIHSIKGKAMTETFAIEINDDFKLATKAGN	MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKPVKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGIEYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQITKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVNDISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAIKYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLGLSIAQKIIQLNGGSIKIKSEINKGTTFKIIF	54.32	gnl|BL_ORD_ID|165|hsp_num:0	182			183	294	ciprofloxacin; acriflavine; norfloxacin
BGC0000536.1|Nisin_6 # 7181 # 9304 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.363	BGC0000536.1|Nisin_6 	7181	9304	+	Loose	500	29.6462	GOB-51	32.56	3005699	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGACTTTAAGCTCGCAACGAAGGCAGGAAATTAGAGTGAAAAAAATATTAAGTTTTCTTTTTATGGTTGTTTCGTTGGGATTATCAACAACTGTGTATGGGGAGGCAATAAACTCACCACGGTCTTCATCGAACAATGCGAACACAGAATTAATTAGTAAGAATTCTAATACAGGTCACTTCTCAACGGAGGAGTCAACAACTGATTCAGGCAAGCTAAAAGAGCAGAAACCCGTAGTAAAATCGACTACCACAACCGAATCGGTTGAAAGTAGAACTGACACTACTAAAAATTTGTTGCAGACTTCAGATACTCAAAAAGAATCAAAAGCTTCATTGCAAGAAACTCAAGCCAGTTCTGAAACAAGCAAAAATGGAAGTGTTACAAATAAAAGAGTAGTTCCAACGCCTAAAGCTGAGCTGTCTAATCAAAGCAAAGCGGTCACTTCAACACAACCAACTCAACAAAGTAAAAGCCTAAATGACGGGAAAACTAAGGTTAGTTTCGCTGATTCATCACAGATTTCTAAAGAGAATCTAGCTAATTCTAAAGATGAATCTGGTGTAACAGGCAATTCTGCGTCATTATCATATCATGAGACTAGGGAGGGAGTATATCCTAGAAACAATACAGTAGATAATCCCAAAAATCAAAAAGTAAAAACACAGCCTCTATTGACAAGCGATTCTCTTGAAAAGAAAGCGAGTGATTATACTGCTTCACATGATTTTTGGGATTACCAATGGGATATGAAATATGTGACAAATGATGGAGAAAGCTATGTGCTCTACCAGCCTTCAAAGAATATTTCTGTTGGAATAATTGATTCTGGAATTATGGAGGACCACCCTGATTTGTCAAACAGTCTAGGAAATCACTTAGAAAATTTTGTTCCTAAGGGAGGGTTTGATAATGAAGAACCTGACGAAACTGGAAATTCTAGCGCTATTTCGGATGAGATGGGGCATGGGACTGAGGTTGCAGGTCAGATTACAGCAAATGGGAGTATTTTAGGAGTAGCACCGGGTGTTACTGTAAATATCTATAGAGTATTTGGCGAAAGTCTTTCGAAATCGGAATGGGTAGCTAAGGCAATAAGAAAAGCTGCAGATGACGGAAACAAAGTTATCAATATAAGTGCTGGACAGTACCTTATGATCTCAGGCTCATACGATGATGGGACAAATGATTATCAAGAATATCTCGATTATAAAGCGGCAATAGATTATGCGACAAAAAAGGGAAGCATAGTTGTTGCGGCCCTTGGTAATGATAGTTTAAACACACAAGATAACCAAGAAATGATAAACTATCTTAAGGAGTATAGAAATATAAAGGTTCCTGGGAAAGTTGTGGATGCTCCAAGTGTATTCGAAGATGTAATAGCGGTAGGTGGAATAGATGGATCTGGCAATATTTCCGATTTTAGTAATGTTGCTCCAGGTGCTATCTATGCGCCTGCTGGAACAACAGTTGATTTGAAAAAATATGGTCAAGATGAATTTGTCAATCAAGGTTATTATTCGAAAGACTGGATTTTTACAACTACTAATACTGGTTGGTATCAATATGTATATGGAAACTCATTTGCGGCTCCCAAGGTATCTGGAGCACTGGCATTAGTGGCTGATAAATATGGTATAAAGAATCCTAAGCAACTGAAAAAATTCCTTCTCACGAATTCTCCAGAAGTTAATGGGGTAAAAGTGTTAAATGTTGTTGATTTGTTGAATGAAAAAAATAAGGCTAGTAATTCGGATACGAATAAAAATCATGGTATTTCTTCTAACAATAAATCAACTGGAAGTTCACAAGTATCTGAACTTGGAAAGGGAAAAATGGGACAAGATAAAGATAAAGAAATTCAGAATAATACAAAGAAAAGCTATCATGGTTCTGATATTGAAAATAATCAGAATGAAATTTCTAAAGAAGTAATTTCAGCTGATTATAGCATTAATCAAAAAAGGAATAATAAACGAAACTTGAGAGGGGCTGTTTCCGTACGAAGTCAAGAAATTTTACCTACCACTGGGGATGAAAGAGGAGATTTTTTACCTGTTTTAGGTGCATTGGGTATTGTAAGCTCTGGTCTATTGAAAAGAAAAAAATCAAAAAATTGA	MTLSSQRRQEIRVKKILSFLFMVVSLGLSTTVYGEAINSPRSSSNNANTELISKNSNTGHFSTEESTTDSGKLKEQKPVVKSTTTTESVESRTDTTKNLLQTSDTQKESKASLQETQASSETSKNGSVTNKRVVPTPKAELSNQSKAVTSTQPTQQSKSLNDGKTKVSFADSSQISKENLANSKDESGVTGNSASLSYHETREGVYPRNNTVDNPKNQKVKTQPLLTSDSLEKKASDYTASHDFWDYQWDMKYVTNDGESYVLYQPSKNISVGIIDSGIMEDHPDLSNSLGNHLENFVPKGGFDNEEPDETGNSSAISDEMGHGTEVAGQITANGSILGVAPGVTVNIYRVFGESLSKSEWVAKAIRKAADDGNKVINISAGQYLMISGSYDDGTNDYQEYLDYKAAIDYATKKGSIVVAALGNDSLNTQDNQEMINYLKEYRNIKVPGKVVDAPSVFEDVIAVGGIDGSGNISDFSNVAPGAIYAPAGTTVDLKKYGQDEFVNQGYYSKDWIFTTTNTGWYQYVYGNSFAAPKVSGALALVADKYGIKNPKQLKKFLLTNSPEVNGVKVLNVVDLLNEKNKASNSDTNKNHGISSNNKSTGSSQVSELGKGKMGQDKDKEIQNNTKKSYHGSDIENNQNEISKEVISADYSINQKRNNKRNLRGAVSVRSQEILPTTGDERGDFLPVLGALGIVSSGLLKRKKSKN	MKRITTLLFLLVCFGWNAQVVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGLAGSLSTIKENIAKLGFNYKDIKILLLTQAHYDHTGALMDFKTETGAKFYADAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSCSFVFDTNDGKRKYRVLIANMPSIIVDNKFSEVTAYPNIQSDYAYTFNAMKKLDFDIWVASHASQFDLHEKRKEGEPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK	243.79	gnl|BL_ORD_ID|3594|hsp_num:0	4663			0	129	
BGC0000536.1|Nisin_7 # 9370 # 10056 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.370	BGC0000536.1|Nisin_7 	9370	10056	+	Loose	400	146.747	vanR gene in vanM cluster	37.55	3002928	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGTATAAAATTTTAATCGTTGATGACGATCAAGAAATTTTAAAGTTAATGAAGACAGCACTCGAAATGAGAAACTATGAAGTTGTGACGCGCCAAGAAGTTTCTCTTCCCCTGAATATTGATGATTTTCAGGGGTTTGATTTGATATTGCTTGATATCATGATGTCAAATATTGAAGGGACAGAAATCTGCAAGAGAATTCGTCGGGAAGTATCAATTCCAATTATTTTTGTTAGTGCAAAAGATACAGAAGAAGACATTGTAAATGGCTTAGGTATTGGTGGAGATGACTATATTACCAAGCCTTTTAGTCTTAAACAGCTGGTTGCAAAAGTAGAAGCAAATATAAAGCGCGAGGAGCGCAATAAACAAGCGGTTCAGGATTTTTCAGAGGTCCGTAGGGACCTAGGGACAATCACATTTTATTTGGAAGAACGCCGCGTATGCGTAAATGGTCAAACTATTCCGTTGACCAGTCGTGAATATGACATCCTTGAGTTACTATCGAGACGAACTTCAAAAGTTTATACGAGAGAGGATATTTATGATGAAGTGTACGATGAGTATGCAGATGCTCTTTTTCGGTCAATTTCAGAATACATTTATCAGATTAGGAATAAGTTTGCACCATATAATATTGATCCGATAAAAACGGTTCGAGGACTAGGGTATAAATGGCATGACTAA	MYKILIVDDDQEILKLMKTALEMRNYEVVTRQEVSLPLNIDDFQGFDLILLDIMMSNIEGTEICKRIRREVSIPIIFVSAKDTEEDIVNGLGIGGDDYITKPFSLKQLVAKVEANIKREERNKQAVQDFSEVRRDLGTITFYLEERRVCVNGQTIPLTSREYDILELLSRRTSKVYTREDIYDEVYDEYADALFRSISEYIYQIRNKFAPYNIDPIKTVRGLGYKWHD	MRRISILIAEDEEEIADLLAIHLEKEGYDVIKVHDGQEALHVIQAQSIDLIILDIMMPKMDGYEVTRQVRAQYNMPIIFLSAKTSDFDKVHGLVIGGDDYITKPFTPIELVARVNAQLRRSMKLNHPQADDKKSILEFGEIVISPDQRTVFLYGENIGLTPKEFDILYLLASHPKKVYSVENIFQQVWNDAYFGGGNTVMVHIRTLRKKLGEDKRKNKLIKTVWGVGYTFNG	98.28	gnl|BL_ORD_ID|4735|hsp_num:0	752			15	693	vancomycin; teicoplanin
BGC0000536.1|Nisin_8 # 10067 # 11392 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.351	BGC0000536.1|Nisin_8 	10067	11392	+	Loose	800	54.6842	ParS	21.13	3005067	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGCGTCGGCGTGTATGGCAATCTGTCATTGAAATTGTCATTGGTACTTTTCTACTTATCATTCTACTATTAGGTTTAACTTTCTTCTTAAGACAGATTGGTCAAATCAGTGGTTCAGGTACTGTTCGTTTATCTTTAGATTCAGATGATCTCACGGTCTCTGATATTAAACGTGACATGGCACACTACCCTTATGACTATATTATCTTTGACAATGATACGAGTAAAATTTTAGGAGGACGCTACGTCAAATCAGATGTATCAAGTTTCGAATCTTCAAAGCAACTTTCAAAAAGTGTTGTAAAAGGGGAAATCACTTATACTTATTCAAGTAATAAGCAGTTTACACTTATTTTAAGACAAAGCAGTATTCCAGAGTTTACTAATCATACGCTGCGTTCAATTTATTACAACCAGTTCACTTACCTCTTCTTTTTCATTGGAGAAATTATCCTTATCAGTTTTTCGGTTTATCGACTCATTCGAGAGTTTTCAAAAAACTTTCAATCTGTTCAAAAAATCGCGTTGAATATGGGGAAAATAACCACTTTTCCCGAACAAGAACAATCAAAAATTACTGAGTTTGATCGGGTTCTCACGAATTTGTATGCAAAAAGTGAGGAGTTAGCTCTACTAATTGAAGCCGAGCGTCGCGAAAAAAAAGATTTATCTTTCCAAGTTGCAGCACTTTCGCATGATGTCAAGACTCCTTTAACAGTTTTAAAAGGAAATATTGAACTGCTTGAGATGACTGAAATGAATGAACAGCAGAATGATTTCATTGGCTCAATGAAAAACAGCTTGGCTGTTTTTGATAAATATTTTAATTCAATGATTAGTTACACAAAACTTCTCAATGATGAAAATGATTACAAGATGAAAATTTCTCTAGAAGACTTTTTGACAGATTTGTCGGTTGAACTAGAAGAATTATCAGCAACCTATCAGGTAGATTACCAGTTAAATGTAAAGACAGAATTAGAAACTTTTCACGGGAATACATTAGCTCTGAGTCGGGCACTTACCAATGTTTTTGTCAATGCCTGTCAATATGCCAAAGATGGTGAAAAGAAAGTCAGTTTGAGCATTTGTGATGACGAAAAGTATCTCTATTTCGTTATTTGGAATAATGGTCAGCCCTTTTCTGACCAAGCGAAAAAAAATGCAGGTAAACTATTTTTTACGGAAGATGCTGGACGAAGTGGGAAACATTATGGTATTGGTCTCTCTTTTGCCCAAGGTGTTGCCTTGAAACATCAAGGGAATCTAATTCTCAGTAATCCAGAGAATGGTGGGGCAGAAGTTGTCATAAAAATAAGGAAGTAA	MRRRVWQSVIEIVIGTFLLIILLLGLTFFLRQIGQISGSGTVRLSLDSDDLTVSDIKRDMAHYPYDYIIFDNDTSKILGGRYVKSDVSSFESSKQLSKSVVKGEITYTYSSNKQFTLILRQSSIPEFTNHTLRSIYYNQFTYLFFFIGEIILISFSVYRLIREFSKNFQSVQKIALNMGKITTFPEQEQSKITEFDRVLTNLYAKSEELALLIEAERREKKDLSFQVAALSHDVKTPLTVLKGNIELLEMTEMNEQQNDFIGSMKNSLAVFDKYFNSMISYTKLLNDENDYKMKISLEDFLTDLSVELEELSATYQVDYQLNVKTELETFHGNTLALSRALTNVFVNACQYAKDGEKKVSLSICDDEKYLYFVIWNNGQPFSDQAKKNAGKLFFTEDAGRSGKHYGIGLSFAQGVALKHQGNLILSNPENGGAEVVIKIRK	MLRLFLRLYLLLALGFAAAIFVVDHVIDAFYDSIVENYHRDAVRGQAYSLVEKLAPLDQAGRQRQLEDWRPHYGLELSLTDARQAKLTQEEQALLDKNLLVVREDFTEFISRIDAGPQLLDIKLPPEPSLTPLFTVLAYILLGVLVGIALLVWVRPHWRDLETLRLAAQRFGDGDLSSRTRIFRRSDIRTLAQHFNQMADRIESLISNQRELTNAVSHELRTPISRLSFELEQLNKQVDAEVRHDLIEDMRADLGELEEMVSELLTYARLEHGNVGSHREIVDAASWLDSVVADVALEAEAAGVTCEISACQVEQIRIEPRFMARAVINLLRNAIRHAHSRVEIALLDQGDSCQIRVNDDGPGIPADARQKIFEPFSRLDDSRDRSTGGFGLGLAIVHRVAQWHGGYAEALETPQGGASFRLTWERPR	103.04	gnl|BL_ORD_ID|2790|hsp_num:0	3805			642	1257	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000536.1|Nisin_9 # 11490 # 12167 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.370	BGC0000536.1|Nisin_9 	11490	12167	+	Loose	570	166.777	bcrA	42.79	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGAGTTGAAATTCAAAATCTCTCTAAAGAGTATAAAGAAAAGCAGGTACTACAAGACATCAGTTTTAACATTGAGTCGGGAACAGTTTGTGGACTATTAGGGGTTAATGGTGCGGGTAAATCGACTTTGATGAAAATACTATTTGGCTTGATTTCCGCAGATTCTGGAAAAATTTGCTTTGATGGGCAGCAAAAAGCAAGCAATCAGATAGGAGCTTTGATTGAAGCTCCAGCGATTTATATGAATTTATCCGCCTTTGATAATCTTAAAACGAAAGCTTTGCTTTTTGGAATTTCAGATAAGAAAATTCATGAAACACTGGAAGTGATTGGTTTGGCAGAGACAGGAAAGAAAAGAGCTGGAAAATTCTCTTTAGGGATGAAACAAAGGTTGGGAATCGGTATGGCCATTCTGACAGAACCTCATTTCTTGATTCTTGATGAGCCTACTAATGGCTTAGATCCTGACGGAATTGCGGAATTGTTAAACTTAATTGCTAAACTTAAAGCGCAAGGTGTGACAGTTTTAATTTCTAGTCATCAATTGCATGAGGTGAGCAAAGTAGCTGATCAAATTGTCATTTTGAATCAAGGCAGAATTTGTTATAACCATGCGAATAATCAAGAAGACGACATTGAACAGCTCTTCTTTAAAATTGTACACGGAGGAATGTGA	MRVEIQNLSKEYKEKQVLQDISFNIESGTVCGLLGVNGAGKSTLMKILFGLISADSGKICFDGQQKASNQIGALIEAPAIYMNLSAFDNLKTKALLFGISDKKIHETLEVIGLAETGKKRAGKFSLGMKQRLGIGMAILTEPHFLILDEPTNGLDPDGIAELLNLIAKLKAQGVTVLISSHQLHEVSKVADQIVILNQGRICYNHANNQEDDIEQLFFKIVHGGM	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	73.53	gnl|BL_ORD_ID|315|hsp_num:0	345			12	636	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000536.1|Nisin_10 # 12169 # 12897 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.373	BGC0000536.1|Nisin_10 	12169	12897	+	Loose	520	25.7942	OXA-478	44.0	3003635	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAAAGAATGTTGGCATCAGAGACATTAAAATTAAAAAGATCTGGAACGCTTAGATTAGCAATGATTATTCCTTTTGTGACACTATTTATAGCGTTTCTTATGGGGGGAATGCAGATTTTTGCCGCATTTTCAATTTATTGGTGGGAAGCTGGCTTTTTATTCCTTTTGATAAGTTTACTTTTTCTCTATGATAAAAAATCAGAGGAGAAAGCTGGGAACTTTCAAAATGTGAATTCAGAAGACTTGAGTTGGAAAATTCATTTGGTGAAAATGTTGTTGATCTGGTTGAGAGGGCTGATTGCGAGCTTAGTCTTAGCCGTTTTACTCTATTTGGTCGCTTGGATTTTCCAAGGAATTGTGGTTGTGGATTTTATGAAAGTGAGTGTGGCACTGCTTGCCATTTTACTAGCAGCCGCTTGGAATCTCCCATTACTATACGTGCTTTCCAAGTGGTTTAACACCTATGTACTGATAGCTGCGAATTCTTTGCTTTGCTTGATTGTTGCACCTTTCATCGCACAGACACCTATATGGTTTTTACTGCCATACACTTATCACTATAAAGTTGTGGAGAGCTTGCTACATATTAAACCAGCAGGAGATTTGCTGGAAAAGACGGTAAATTTCAATATCTGGGAAGTTTTATTACCTATTGGACTTTCCATAGTGGTGACAATAGGGCTTTCATATGTGCTTAAAGGAGTATTAGAACATGATAAGAAGTGA	MKRMLASETLKLKRSGTLRLAMIIPFVTLFIAFLMGGMQIFAAFSIYWWEAGFLFLLISLLFLYDKKSEEKAGNFQNVNSEDLSWKIHLVKMLLIWLRGLIASLVLAVLLYLVAWIFQGIVVVDFMKVSVALLAILLAAAWNLPLLYVLSKWFNTYVLIAANSLLCLIVAPFIAQTPIWFLLPYTYHYKVVESLLHIKPAGDLLEKTVNFNIWEVLLPIGLSIVVTIGLSYVLKGVLEHDKK	MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAELRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNSRYAIKNSQVPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFGIEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTYNYTLHGKTGLVDSKNMTTEPIGWFVGWLEENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	89.96	gnl|BL_ORD_ID|2095|hsp_num:0	3540			723	798	cloxacillin; oxacillin; cefalotin
BGC0000536.1|Nisin_11 # 12884 # 13528 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.355	BGC0000536.1|Nisin_11 	12884	13528	+	Loose	750	26.5646	bmr	28.57	3003007	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; nucleoside antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATAAGAAGTGAATGTCTCAAATTAAAAAATAGCTCTGGACTTTATTTGGTTTTCCTCTTTACCTTATTAGAGGTATTGACAATCCCAATATATTTAGCTTTTGGACGAAGCATTGTTTCAATGACCGATTTGTCACTCATGACACTTTTGTTCTTTCCATTATTGGCTGCAATTTTGTCTATTCTTACCTTTGAGCAGGAGAGTTTAGCCAATCATTTTCAAGAAATAAAAGCAAATAAAAAAACCAGCAGAATTTGGCTATCAAAGCTGGTTGTAGTTGACTTGCTTTTGTTCTTTCCTTCAGCAATGATCTGGCTAATTACGGGAATCTCACAGGGAAAAGGCGGAGAAGGGCTGTTAATTGCATCAGCTAGTTGGTTGATGGCGATTTTCCTCAATCATTTTCATCTTTTATTGACCTTTGTTCTCAATCGAGGAGGCAATATTATTGTTGCGATTGTCGAAATCTTGCTCATTGTTTTTGCTAGTAATAAAGTTTTGCTAGGAGCTTATTGGTGCCCTATTGCCTTACCTGTCAATTTTGTGGTAACAGGAGGATTTAACTATTTAATGGCTGTCGTTATCTGGATTGTTTTGTGTACATTAATTATTGTATCATTACCCAAAAATGCGATCAGATAA	MIRSECLKLKNSSGLYLVFLFTLLEVLTIPIYLAFGRSIVSMTDLSLMTLLFFPLLAAILSILTFEQESLANHFQEIKANKKTSRIWLSKLVVVDLLLFFPSAMIWLITGISQGKGGEGLLIASASWLMAIFLNHFHLLLTFVLNRGGNIIVAIVEILLIVFASNKVLLGAYWCPIALPVNFVVTGGFNYLMAVVIWIVLCTLIIVSLPKNAIR	MEKKNITLTILLTNLFIAFLGIGLVIPVTPTIMNELHLSGTAVGYMVACFAITQLIVSPIAGRWVDRFGRKIMIVIGLLFFSVSEFLFGIGKTVEMLFISRMLGGISAPFIMPGVTAFIADITTIKTRPKALGYMSAAISTGFIIGPGIGGFLAEVHSRLPFFFAAAFALLAAILSILTLREPERNPENQEIKGQKTGFKRIFAPMYFIAFLIILISSFGLASFESLFALFVDHKFGFTASDIAIMITGGAIVGAITQVVLFDRFTRWFGEIHLIRYSLILSTSLVFLLTTVHSYVAILLVTVTVFVGFDLMRPAVTTYLSKIAGNEQGFAGGMNSMFTSIGNVFGPIIGGMLFDIDVNYPFYFATVTLAIGIALTIAWKAPAHLKAST	55.01	gnl|BL_ORD_ID|1152|hsp_num:0	1256			519	783	acriflavine; puromycin; chloramphenicol
BGC0000536.1|Nisin_4 # 5240 # 6481 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.329	BGC0000536.1|Nisin_4 	5240	6481	+	Loose	300	26.1794	Escherichia coli soxR with mutation conferring antibiotic resistance	35.9	3003381	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATAAAAAAATTATTGAAGAAAGTGTTGAAAAAATCATCACTGAATGGGATGAGAAAACTAGAAAAAATAAAGATAAATTCGATTTTGGAGAGTTGACCCTTTCTACAGGGGTGCCAGGTGTAATTTTAATGTTATCTGAGATAAAAGATAATGGGAAATCTAGGATATACCAGAAAAAAATAGACGATTATATTGAATATGTTGTGAGTAAACTCTCAATTCATGGACTTCTAACGGGCTCACTTTATTCAGGAGCGGCTGGTATTGCATTGAGTATTTTACATTTTCGAGAAGACAACAAAAAATATGAGAATCTTCTTAATAGCTTCAATAGATACATTGAATATTTTGTCAAAGAAAAAATTGAAAGATTTAATTTGGAAAGTATTACTCCTCCAGATTATGACGTGATTGAAGGCTTTTCTGGAATACTTTCCTATCTTCTTTTAGTCAACGACGAGCAGTATGATAATTTAAAAAGACTCATCGTCAATTTTCTGTCAGATTTGACTAAAGAAAATAAAGGCCTAATGTCACTTTACATAAAATCAGAGAATCAAATGTCCAAAGCAGAAAGTGAGATGTATCCATTAGGGTGTTTGAACATGGGGCTGGCACATGGTCTTGCGGGAATAGGTAGCATTTTAGCTTATGCGCATATAAAAGGGTACGGTGACAAATCATCATTATCTGCTTTAGAAAAGATTATTTCCGTTTATGAAAAATATGAACTTAAAGAGCAAAATCAGTTTCTTTGGAAAGATGGGCTTGTAGCAGATGAATTAAAAGAAGGGAAAGTAATTAGGGAAGCAAGCTTCATTAGGGATGCATGGTGTTATGGAGGTCCAGGTATTAGTCTTTTATACTTATATGGGGGATTAGCACTAAAAAATGATTATTTTGTGTCTAAAGCAGAAAAAATATTGGAATCAGCCATGCAAAGAAAACTTGGTGTTGACTCATATATGATTTGTCATGGATATTCTGGTTTAATTGAAATTTGCTTGCTATTTAAGCGGTTATTAAATACAAAAATATTTGACCCTTACATAGAAGATTTTAAAGCTAATAGTGAACAAATTCTTAAAGAATATGGAGATGAGAATGGGTCGGGTTTTCTTGAAGGATTAAGTGGTTGTGTCTTAGCTGTGTCGGAATTTGAATATCCAACTCAATCTACTTATTGGAGACAAGCACTGTTACTCTTTGACGATTTCTTGAAAGGAGAGAGAAAATGA	MNKKIIEESVEKIITEWDEKTRKNKDKFDFGELTLSTGVPGVILMLSEIKDNGKSRIYQKKIDDYIEYVVSKLSIHGLLTGSLYSGAAGIALSILHFREDNKKYENLLNSFNRYIEYFVKEKIERFNLESITPPDYDVIEGFSGILSYLLLVNDEQYDNLKRLIVNFLSDLTKENKGLMSLYIKSENQMSKAESEMYPLGCLNMGLAHGLAGIGSILAYAHIKGYGDKSSLSALEKIISVYEKYELKEQNQFLWKDGLVADELKEGKVIREASFIRDAWCYGGPGISLLYLYGGLALKNDYFVSKAEKILESAMQRKLGVDSYMICHGYSGLIEICLLFKRLLNTKIFDPYIEDFKANSEQILKEYGDENGSGFLEGLSGCVLAVSEFEYPTQSTYWRQALLLFDDFLKGERK	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	268.18	gnl|BL_ORD_ID|1973|hsp_num:0	1005			21	138	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; nalidixic acid; norfloxacin; cefalotin; triclosan
